Cargando…
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases
INTRODUCTION: Responses to COVID-19 vaccination in patients with chronic pulmonary diseases are poorly characterised. We aimed to describe humoral responses following two doses of BNT162b2 mRNA COVID-19 vaccine and identify risk factors for impaired responses. METHODS: Prospective cohort study inclu...
Autores principales: | Harboe, Zitta Barrella, Hamm, Sebastian Rask, Pérez-Alós, Laura, Sivapalan, Pradeesh, Priemé, Helene, Wilcke, Torgny, Kjeldgaard, Peter, Shaker, Saher, Svorre Jordan, Alexander, Møller, Dina Leth, Heftdal, Line Dam, Madsen, Johannes Roth, Bayarri-Olmos, Rafael, Hansen, Cecilie Bo, Pries-Heje, Mia Marie, Hasselbalch, Rasmus Bo, Fogh, Kamille, Armenteros, Jose Juan Almagro, Hilsted, Linda, Sørensen, Erik, Lindegaard, Birgitte, Browatzki, Andrea, Biering-Sørensen, Tor, Frikke-Schmidt, Ruth, Ostrowski, Sisse Rye, Iversen, Kasper Karmark, Bundgaard, Henning, Nielsen, Susanne Dam, Garred, Peter, Jensen, Jens-Ulrik Stæhr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260234/ https://www.ncbi.nlm.nih.gov/pubmed/35793836 http://dx.doi.org/10.1136/bmjresp-2022-001268 |
Ejemplares similares
-
Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023) -
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls
por: Hamm, Sebastian Rask, et al.
Publicado: (2022) -
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection
por: Rezahosseini, Omid, et al.
Publicado: (2023) -
Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination
por: Madsen, Johannes Roth, et al.
Publicado: (2023) -
Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort study
por: Heftdal, Line Dam, et al.
Publicado: (2023)